Department of Trauma and Hand Surgery, University Hospital Düsseldorf, Moorenstrasse 5, D-40225 Düsseldorf, Germany.
Crit Care. 2011;15(1):R20. doi: 10.1186/cc9965. Epub 2011 Jan 13.
Deregulated apoptosis and overshooting neutrophil functions contribute to immune and organ dysfunction in sepsis and multiple organ failure (MOF). In the present study, we determined the role of soluble Fas (sFas) in the regulation of posttraumatic neutrophil extrinsic apoptosis and the development of sepsis.
Forty-seven major trauma patients, 18 with and 29 without sepsis development during the first 10 days after trauma, were enrolled in this prospective study. Seventeen healthy volunteers served as controls. Blood samples from severely injured patients were analyzed at day 1, day 5 and day 9 after major trauma. sFas levels, plasma levels of neutrophil elastase (PMNE) and levels of interleukin (IL)-6 were quantified by enzyme-linked immunosorbent assay and related to patients' Sequential Organ Failure Assessment (SOFA) score and Multiple Organ Dysfunction Score (MODS). Neutrophil apoptosis was determined by propidium iodide staining of fragmented DNA and flow cytometry. sFas-mediated effects on neutrophil apoptosis were investigated in cells cultured with agonistic anti-Fas antibodies in the presence of recombinant sFas, sFas-depleted serum or untreated serum from septic patients.
Serum levels of sFas in patients who later developed sepsis were significantly increased at day 5 (P < 0.01) and day 9 (P < 0.05) after trauma compared with patients with uneventful recovery. Apoptosis of patient neutrophils was significantly decreased during the observation period compared with control cells. Moreover, Fas-mediated apoptosis of control neutrophils was efficiently inhibited by recombinant sFas and serum from septic patients. Depletion of sFas from septic patient sera diminished the antiapoptotic effects. In septic patients, sFas levels were positively correlated with SOFA at day 1 (r = 0.7, P < 0.001), day 5 (r = 0.62, P < 0.01) and day 9 (r = 0.58, P < 0.01) and with PMNE and leukocyte counts (r = 0.49, P < 0.05 for both) as well as MODS at day 5 (r = 0.56, P < 0.01) after trauma.
Increased sFas in patients with sepsis development impairs neutrophil extrinsic apoptosis and shows a positive correlation with the organ dysfunction scores and PMNE. Therefore, sFas might be a therapeutic target to prevent posttrauma hyperinflammation and sepsis.
凋亡失调和中性粒细胞功能过强会导致脓毒症和多器官功能衰竭(MOF)中的免疫和器官功能障碍。在本研究中,我们确定了可溶性 Fas(sFas)在调节创伤后中性粒细胞外在凋亡和脓毒症发展中的作用。
47 名严重创伤患者,其中 18 名在创伤后 10 天内发生脓毒症,29 名未发生脓毒症,纳入本前瞻性研究。17 名健康志愿者作为对照。在创伤后第 1、5 和 9 天分析严重创伤患者的血样。通过酶联免疫吸附试验定量检测 sFas 水平、血浆中性粒细胞弹性蛋白酶(PMNE)水平和白细胞介素(IL)-6 水平,并与患者的序贯器官衰竭评估(SOFA)评分和多器官功能障碍评分(MODS)相关联。通过碘化丙啶染色断裂的 DNA 和流式细胞术测定中性粒细胞凋亡。在存在重组 sFas、sFas 耗尽的血清或来自脓毒症患者的未处理血清的情况下,用激动性抗 Fas 抗体培养细胞,研究 sFas 对中性粒细胞凋亡的影响。
与无并发症恢复的患者相比,创伤后第 5 天(P < 0.01)和第 9 天(P < 0.05),发生脓毒症的患者血清 sFas 水平明显升高。在观察期间,患者中性粒细胞的凋亡明显减少。此外,Fas 介导的对照中性粒细胞凋亡被重组 sFas 和脓毒症患者的血清有效抑制。从脓毒症患者的血清中去除 sFas 可减弱抗凋亡作用。在脓毒症患者中,sFas 水平与第 1 天(r = 0.7,P < 0.001)、第 5 天(r = 0.62,P < 0.01)和第 9 天(r = 0.58,P < 0.01)的 SOFA 以及与 PMNE 和白细胞计数(r = 0.49,P < 0.05 )以及创伤后第 5 天的 MODS 呈正相关(r = 0.56,P < 0.01)。
脓毒症患者中 sFas 的增加会损害中性粒细胞外在凋亡,并与器官功能障碍评分和 PMNE 呈正相关。因此,sFas 可能是预防创伤后过度炎症和脓毒症的治疗靶点。